Rosenblat M[au] - Search Results

Year	Number of Results
1950	1
1965	1
1986	1
1988	1
1989	2
1991	2
1992	2
1994	1
1995	1
1996	3
1997	3
1998	6
1999	2
2000	4
2002	6
2003	5
2004	4
2005	5
2006	7
2007	2
2008	6
2009	7
2010	5
2011	3
2012	4
2013	6
2014	6
2015	7
2016	3
2018	1
2019	2
2020	3
2021	1
2022	1
2023	1
2024	1

1

Polarized vs. Threshold Training Intensity Distribution on Endurance Sport Performance: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Rosenblat MA, Perrotta AS, Vicenzino B. Rosenblat MA, et al. J Strength Cond Res. 2019 Dec;33(12):3491-3500. doi: 10.1519/JSC.0000000000002618. J Strength Cond Res. 2019. PMID: 29863593

2

Paraoxonases role in the prevention of cardiovascular diseases.

Rosenblat M, Aviram M. Rosenblat M, et al. Biofactors. 2009 Jan-Feb;35(1):98-104. doi: 10.1002/biof.16. Biofactors. 2009. PMID: 19319852 Review.

3

Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences.

Aviram M, Rosenblat M. Aviram M, et al. Among authors: rosenblat m. Curr Opin Lipidol. 2005 Aug;16(4):393-9. doi: 10.1097/01.mol.0000174398.84185.0f. Curr Opin Lipidol. 2005. PMID: 15990587 Review.

4

Pomegranate for your cardiovascular health.

Aviram M, Rosenblat M. Aviram M, et al. Among authors: rosenblat m. Rambam Maimonides Med J. 2013 Apr 30;4(2):e0013. doi: 10.5041/RMMJ.10113. Print 2013 Apr. Rambam Maimonides Med J. 2013. PMID: 23908863 Free PMC article.

5

Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development.

Aviram M, Kaplan M, Rosenblat M, Fuhrman B. Aviram M, et al. Among authors: rosenblat m. Handb Exp Pharmacol. 2005;(170):263-300. doi: 10.1007/3-540-27661-0_9. Handb Exp Pharmacol. 2005. PMID: 16596803 Review.

6

Pomegranate Protection against Cardiovascular Diseases.

Aviram M, Rosenblat M. Aviram M, et al. Among authors: rosenblat m. Evid Based Complement Alternat Med. 2012;2012:382763. doi: 10.1155/2012/382763. Epub 2012 Nov 18. Evid Based Complement Alternat Med. 2012. PMID: 23243442 Free PMC article.

7

Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.

Aviram M, Rosenblat M. Aviram M, et al. Among authors: rosenblat m. Free Radic Biol Med. 2004 Nov 1;37(9):1304-16. doi: 10.1016/j.freeradbiomed.2004.06.030. Free Radic Biol Med. 2004. PMID: 15454271 Review.

8

Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.

Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, Hofman A, Rosenblat M, Volkova N, Presser D, Attias J, Hayek T, Fuhrman B. Aviram M, et al. Among authors: rosenblat m. Drugs Exp Clin Res. 2002;28(2-3):49-62. Drugs Exp Clin Res. 2002. PMID: 12224378 Review.

9

Revealing the 'obscurin': mapping the path to new discovery with the phosphoproteome.

Waskiw-Ford M, Fung HJW, Gavel E, Ivanisevic O, Malowany JM, Rosenblat M. Waskiw-Ford M, et al. Among authors: rosenblat m. J Physiol. 2018 Mar 15;596(6):961-962. doi: 10.1113/JP275766. Epub 2018 Feb 12. J Physiol. 2018. PMID: 29363132 Free PMC article. No abstract available.

10

Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation.

Rosenblat M, Volkova N, Ward J, Aviram M. Rosenblat M, et al. Atherosclerosis. 2011 Nov;219(1):49-56. doi: 10.1016/j.atherosclerosis.2011.06.054. Epub 2011 Jul 12. Atherosclerosis. 2011. PMID: 21798540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year